About: Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1998 (uk) im April 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1998 (ast) scientific article published on 01 April 1998 (en)
publication date	wds:Q74587622-42E135A2-EEBE-4555-929E-4B79AA980B96
publication date	1998-04-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q74587622-0B71108A-3D36-4008-A658-6E2D07CD3242 wds:Q74587622-13B44F70-D194-429F-8F6E-B493148DB2A3 wds:Q74587622-17C26F95-D523-4441-9C90-E835DCD12EA2 wds:Q74587622-2EABDBB9-EB3E-4B14-B97A-EA07AA132FCF wds:Q74587622-30580816-C9EE-4DA1-A69E-197372D6E53A wds:Q74587622-3663B1D2-53C4-446E-88A0-504481DD4E01 wds:Q74587622-41F8ADCF-ECBA-4049-98F1-69C5D56C3746 wds:Q74587622-510F0018-5074-4935-A1FB-3534FDBC306C wds:Q74587622-531A01E9-EBBA-4D00-8661-F4025DA4E71D wds:Q74587622-5AF14CAE-A8BE-4ADD-A94B-2650056B90F6 wds:Q74587622-7A2D1E05-D2B5-46A1-B132-42F7C4B6C8E5 wds:Q74587622-B1F78934-F477-4274-B435-0EF37FB35B2E wds:Q74587622-B3D2003E-23B6-430A-8C23-089472D27096 wds:Q74587622-BD7CD2F4-9108-4B7B-9C1F-3EABEF738D9A wds:Q74587622-BE56DA43-343E-48C4-9DC2-B934B02ABDD4 wds:Q74587622-C613CCA0-BA0D-4538-B37F-2C2EB06D0ED2 wds:Q74587622-C7533FB2-4474-4D44-9A3D-94B7EC63CBE8 wds:Q74587622-C8E5D703-E80B-4462-92FA-7E7354B273D0 wds:Q74587622-CAFC613C-D222-455D-8B05-EC1204D74865 wds:Q74587622-D4D27DA7-190B-426C-B633-930C201AA3C7 wds:Q74587622-DB0A0179-48DE-45D2-BF25-760854428CC8 wds:Q74587622-DFEFD595-EA79-4E31-A24F-003DFB3C322B wds:Q74587622-E4A0F18F-38F0-44A1-804D-5151038C31C1 wds:Q74587622-E7FBD756-5E24-4052-9F8F-AFD88FA8A090 wds:Q74587622-EB4B5ED0-B2C9-4915-9B1F-ECBB74E9F899 wds:Q74587622-EEE6498D-3AF6-4F46-9885-5422D6DF6EF9 wds:Q74587622-FCCD5BC8-DB22-42A3-B3B5-91B41D8ED488
cites work	Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group Regulation of lymphocyte mitogenesis by (2′–5′) oligo-isoadenylate Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Clinical viral infections and multiple sclerosis. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells The interferons: biological effects, mechanisms of action, and use in multiple sclerosis Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes Suppression of experimental allergic encephalomyelitis by interferon Mercuric chloride down-regulates T cell interferon-gamma production in brown Norway but not in Lewis rats; role of glutathione Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes Assessment of the inhibitory effect of immunosuppressive agents on rat T cell interferon-gamma production using an ELISPOT assay Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE Pathogenesis and immunotherapy of autoimmune diseases
author name string	wds:Q74587622-42488624-3EA6-4AFD-8A35-2A0E60B9C005 wds:Q74587622-47FEB453-B46B-4F1F-9EC2-21A7CD19521B wds:Q74587622-570D4A7D-8BA6-48D2-8CB5-5DA24969E87D wds:Q74587622-BB0EE899-70EC-4D9F-9122-E2C06112DA2F wds:Q74587622-CB4A7CA3-DC47-4C48-9BAF-4CB79DA06884 wds:Q74587622-F6B7969D-1015-4914-B92F-BBA1120D5715 wds:Q74587622-F6FB829F-5EB5-440D-A836-09D1955A408A
author name string	T Olsson C D Dijkstra S R Ruuls P H van der Meide M C de Labie C A Botman R J Groenestein
rdfs:label	Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (en) Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (nl)
skos:prefLabel	Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (en) Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (nl)
name	Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (en) Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease prom (nl)
title	wds:Q74587622-10A16215-119B-4B6B-8329-7F067754E8F4
title	Discontinuation of treatment with IFN-beta leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-beta and excessive expansion of autoreactive T cells as disease promoting mechanisms (en)
page(s)	wds:Q74587622-072472ED-644E-4991-8562-E75A8A837939
page(s)	14-23
instance of	wds:Q74587622-82FBBC82-73A6-4B10-AD97-7E13CC4DA3FC
instance of	scholarly article
main subject	wds:Q74587622-719E8227-4415-4557-A31C-363A0C26CF47
main subject	experimental autoimmune encephalomyelitis
PubMed ID	wds:Q74587622-1E1FF202-F91D-48A1-AEE7-B84CD82E47BB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9600704
PubMed ID	9600704
published in	wds:Q74587622-2EFFA1F3-1FCF-400C-98BC-1FF95A357DAC
published in	Journal of Neuroimmunology
issue	wds:Q74587622-E81ADBB9-8558-435E-8AE1-6CAD759C18EC
volume	wds:Q74587622-FFF86937-A19B-4597-95B0-2777D48F6F79
issue	1
volume	84
DOI	wds:Q74587622-6F2EC33E-9511-4DCB-BD30-09D4010DEDD1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software